Commissioner Kyriakidou announced proposals for actions to improve access to medical devices
A list of actions to support the capacities of notified authorities (the authorities designated by Member States to assess whether certain products comply with EU technical specifications), and the preparation of medical device manufacturers for the entry into force of the new relevant Regulations, has been approved by the Commission's competent technical body.
Explaining the decision, Health Commissioner Stella Kyriakidou noted that the relevant rules "ensure that patients in the European Union will have access to safe, life-saving medical devices."
"The measures we are announcing today aim to address the short-term challenges related to the availability of medical devices to patients in the EU," she noted.
"Through cooperation, we are committed to developing sustainable solutions to ensure that these products are available at all times and to avoid shortages," he added.
The measures were adopted by the Medical Devices Coordination Group (MDCG), chaired by the Commission, following the meeting of the EU Health Council of Ministers held on 14 June, and concern the transition to the Medical Devices Regulation and the In Vitro Diagnostic Medical Devices Regulation.
Among other things, the Coordination Body for Medical Devices recommends that notified bodies carry out hybrid audits, conduct structured dialogues with manufacturers to improve the efficiency of the assessment process, and provide support to SMEs and new applicants. At the same time, manufacturers are urged to make every effort to comply with the new requirements in a timely manner.
As mentioned, the Commission's coordinating body will continue to monitor the sector, and the Commission will report to the Council in December 2022.
Source: CNA
Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times
Source